3TC
As listed in the register: 3TC
150 mg · tablet
- Prescription only
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Lamivudine
- Made by
- Viiv Healthcare Ulc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Lamivudine). It describes the substance, not this exact product.
Lamivudine is an antiviral agent with activity against HBV [see Microbiology ( 12.4 )].
Lamivudine is not significantly metabolized by cytochrome P450 enzymes.
The majority of lamivudine is eliminated unchanged in urine by active organic cationic secretion.
Effects of Food on Oral Absorption: Lamivudine tablets (HBV) may be administered with or without food.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-07-29
Safety of the active substance
From the US prescribing label for the same active substance (Lamivudine). It describes the substance, not this exact product.
WARNING: EXACERBATIONS OF HEPATITIS B and RISK OF HIV-1 RESISTANCE IF LAMIVUDINE TABLETS (HBV) IS USED IN PATIENTS WITH UNRECOGNIZED OR UNTREATED HIV-1 INFECTION Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued anti-hepatitis B therapy (including lamivudine tablets (HBV).
- Lamivudine tablets (HBV) are contraindicated in patients with a previous hypersensitivity reaction to lamivudine.
- Lamivudine tablets (HBV) is contraindicated in patients with previous hypersensitivity reaction to lamivudine.
The most common reported adverse reactions in those receiving lamivudine tablets (HBV) (incidence greater than or equal to 10% and reported at a rate greater than placebo) were ear, nose, and throat infections; sore throat; and diarrhea.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States12 matching products
European UnionNo exact match for this strength and form
Spain5 matching products
France5 matching products
Netherlands5 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Viiv Healthcare Ulc |
|---|---|
| Active substance | Lamivudine |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Strength | 150 mg |
| Form | tablet |
| Classification | J05AF05 · Antibiotics, antivirals and antifungals taken into the body |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02192683 |
| DPD drug code | 19614 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.